Second malignant neoplasms (SMN) or second cancers may occur in 2-5 % of childhood cancer survivors within 5-25 years after diagnosis and treatment of a bone sarcoma. The most common are leukemia and breast cancer; salivary gland SMN are exceptional. To enhance the literature, we reviewed our patients with bone sarcomas and evaluated the incidence and outcome of salivary gland SMN.
Salivary gland second cancer after bone sarcoma treatment / Longhi, A.; Errani, C.; Gambarotti, M.; Ferrari, C.; Kreshak, J.; Panagopoulos, G.N.; Mavrogenis, A.F.; Donati, D.. - In: EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY & TRAUMATOLOGY. - ISSN 1633-8065. - STAMPA. - 25:7(2015), pp. 1201-1204. [10.1007/s00590-015-1662-x]
Salivary gland second cancer after bone sarcoma treatment
LONGHI, ALESSANDRA;ERRANI, COSTANTINO;GAMBAROTTI, MARCO;DONATI, DAVIDE MARIA
2015
Abstract
Second malignant neoplasms (SMN) or second cancers may occur in 2-5 % of childhood cancer survivors within 5-25 years after diagnosis and treatment of a bone sarcoma. The most common are leukemia and breast cancer; salivary gland SMN are exceptional. To enhance the literature, we reviewed our patients with bone sarcomas and evaluated the incidence and outcome of salivary gland SMN.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
